← Back to headlines
Vertex Pharmaceuticals to Acquire Crinetics for $10 Billion
Vertex Pharmaceuticals has announced its intention to acquire Crinetics Pharmaceuticals for $10 billion, a move aimed at expanding its business in the rare-disease treatment sector.
6 Jul, 20:21 — 6 Jul, 20:21
Sources
Showing 1 of 1 sources
